
 |
| 2004 Parts B and C Grant Award Application Packages
(Dec 04, 2003)
|
| 2004 Parts B and C Grant Award Application Packages for IDEA. |
 |
| 2005 Parts B and C Grant Award Application Packages
(Mar 02, 2005)
|
| 2005 Parts B and C Grant Award Application Packages for IDEA. |
 |
| Annual State Application Under Part B Of the Individuals With Disabiliteis Education Act for Federal Fiscal Year 2004 (CFDA Nos. 84.027 and 84.173)
(Dec 04, 2003)
|
| Cover Page and Application Parts I and II to apply for Funds Under Part B of IDEA FFY 2004. |
 |
| Annual State Application Under Part B Of the Individuals With Disabiliteis Education Act for Federal Fiscal Year 2005 (CFDA Nos. 84.027 and 84.173) (MS Word)
(Mar 02, 2005)
|
| Cover Page and Application Parts I and II to apply for Funds Under Part B of IDEA FFY 2005. |
 |
| Annual State Application Under Part B of the Individuals with Disabilities Education Act (MS Word)
(Mar 02, 2005)
|
| Submission Statement for Part B in IDEA |
 |
| Annual State Application Under Part C of the Individuals with Disabilities Education Act (MS Word)
(Mar 02, 2005)
|
| Submission Statement for Part C in IDEA |
 |
| Appendix B: EDGAR 34 CFR 76.703; When A State May Begin To Obligate Funds
(Dec 03, 2003)
|
| Timing of Grant allocation According to the Education Department General Administrative Regulations (EDGAR). Appendix B. |
 |
| Certifications Regarding Lobbying; debarment, Suspension And Other responsibility Matters; Drug-Free Workplace Requirements
(Dec 04, 2003)
|
| Outlines the guidelines for lobbying and requirements grantees to maintain a drug-free workplace. |
 |
| Certifications Regarding Lobbying; debarment, Suspension And Other responsibility Matters; Drug-Free Workplace Requirements (MS Word)
(Mar 02, 2005)
|
| Outlines the guidelines for lobbying and requirements grantees to maintain a drug-free workplace. |
 |
| Certifications Regarding Lobbying; debarment, Suspension And Other responsibility Matters; Drug-Free Workplace Requirements (MS Word)
(Mar 02, 2005)
|
| Outlines the guidelines for lobbying and requirements grantees to maintain a drug-free workplace. |
 |